Literature DB >> 20547007

No association between oxytocin or prolactin gene variants and childhood-onset mood disorders.

John S Strauss1, Natalie L Freeman, Sajid A Shaikh, Agnes Vetró, Eniko Kiss, Krisztina Kapornai, Gabriella Daróczi, Timea Rimay, Viola Osváth Kothencné, Edit Dombovári, Emília Kaczvinszk, Zsuzsa Tamás, Ildikó Baji, Márta Besny, Julia Gádoros, Vincenzo DeLuca, Charles J George, Emma Dempster, Cathy L Barr, Maria Kovacs, James L Kennedy.   

Abstract

BACKGROUND: Oxytocin (OXT) and prolactin (PRL) are neuropeptide hormones that interact with the serotonin system and are involved in the stress response and social affiliation. In human studies, serum OXT and PRL levels have been associated with depression and related phenotypes. Our purpose was to determine if single nucleotide polymorphisms (SNPs) at the loci for OXT, PRL and their receptors, OXTR and PRLR, were associated with childhood-onset mood disorders (COMD).
METHODS: Using 678 families in a family-based association design, we genotyped 16 SNPs at OXT, PRL, OXTR and PRLR to test for association with COMD.
RESULTS: No significant associations were found for SNPs in the OXTR, PRL, or PRLR genes. Two of three SNPs 3' of the OXT gene were associated with COMD (p≤0.02), significant after spectral decomposition, but were not significant after additionally correcting for the number of genes tested. Supplementary analyses of parent-of-origin and proband sex effects for OXT SNPs by Fisher's Exact test were not significant after Bonferroni correction.
CONCLUSIONS: We have examined 16 OXT and PRL system gene variants, with no evidence of statistically significant association after correction for multiple tests.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20547007      PMCID: PMC2941560          DOI: 10.1016/j.psyneuen.2010.04.008

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  61 in total

1.  Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study.

Authors:  Ramin V Parsey; Maria A Oquendo; R Todd Ogden; Doreen M Olvet; Norman Simpson; Yung-Yu Huang; Ronald L Van Heertum; Victoria Arango; J John Mann
Journal:  Biol Psychiatry       Date:  2005-09-09       Impact factor: 13.382

2.  Plasma oxytocin levels in depression and their correlation with the temperament dimension of reward dependence.

Authors:  Caroline J Bell; Helen Nicholson; Roger T Mulder; Sue E Luty; Peter R Joyce
Journal:  J Psychopharmacol       Date:  2006-01-09       Impact factor: 4.153

Review 3.  Complex disease, gender and epigenetics.

Authors:  Zachary Kaminsky; Sun-Chong Wang; Arturas Petronis
Journal:  Ann Med       Date:  2006       Impact factor: 4.709

4.  Clinical features of depressed children and adolescents with various forms of suicidality.

Authors:  Xianchen Liu; Amy L Gentzler; Ping Tepper; Enikö Kiss; Viola Osváth Kothencné; Zsuzsanna Tamás; Agnes Vetró; Maria Kovacs
Journal:  J Clin Psychiatry       Date:  2006-09       Impact factor: 4.384

5.  Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.

Authors:  Francis J McMahon; Silvia Buervenich; Dennis Charney; Robert Lipsky; A John Rush; Alexander F Wilson; Alexa J M Sorant; George J Papanicolaou; Gonzalo Laje; Maurizio Fava; Madhukar H Trivedi; Stephen R Wisniewski; Husseini Manji
Journal:  Am J Hum Genet       Date:  2006-03-20       Impact factor: 11.025

6.  The interface of oxytocin-labeled cells and serotonin transporter-containing fibers in the primate hypothalamus: a substrate for SSRIs therapeutic effects?

Authors:  Ana B F Emiliano; Thomaz Cruz; Valerie Pannoni; Julie L Fudge
Journal:  Neuropsychopharmacology       Date:  2006-10-11       Impact factor: 7.853

7.  Plasma oxytocin levels and anxiety in patients with major depression.

Authors:  G Scantamburlo; M Hansenne; S Fuchs; W Pitchot; P Maréchal; C Pequeux; M Ansseau; J J Legros
Journal:  Psychoneuroendocrinology       Date:  2007-03-23       Impact factor: 4.905

8.  Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism.

Authors:  Suma Jacob; Camille W Brune; C S Carter; Bennett L Leventhal; Catherine Lord; Edwin H Cook
Journal:  Neurosci Lett       Date:  2007-02-03       Impact factor: 3.046

9.  Serum prolactin levels among outpatients with major depressive disorder during the acute phase of treatment with fluoxetine.

Authors:  George I Papakostas; Karen K Miller; Timothy Petersen; Katherine G Sklarsky; Sarah E Hilliker; Anne Klibanski; Maurizio Fava
Journal:  J Clin Psychiatry       Date:  2006-06       Impact factor: 4.384

10.  Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major depressive disorder.

Authors:  Paul G Surtees; Nicholas W J Wainwright; Saffron A G Willis-Owen; Robert Luben; Nicholas E Day; Jonathan Flint
Journal:  Biol Psychiatry       Date:  2005-09-09       Impact factor: 13.382

View more
  3 in total

Review 1.  Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.

Authors:  Teodor T Postolache; Laura Del Bosque-Plata; Serge Jabbour; Michael Vergare; Rongling Wu; Claudia Gragnoli
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-02-06       Impact factor: 3.568

2.  Towards Identifying Genetic Biomarkers for Gastrointestinal Dysfunction in Autism.

Authors:  A E Shindler; E L Hill-Yardin; S Petrovski; N Bishop; A E Franks
Journal:  J Autism Dev Disord       Date:  2020-01

3.  Interaction between oxytocin genotypes and early experience predicts quality of mothering and postpartum mood.

Authors:  Viara Mileva-Seitz; Meir Steiner; Leslie Atkinson; Michael J Meaney; Robert Levitan; James L Kennedy; Marla B Sokolowski; Alison S Fleming
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.